Momentum continues at Xenith IP

Morgans Financial Limited

Morgans Financial Limited

Xenith IP Group (XIP) has upgraded EBITDA guidance from prospectus forecasts of A$7.5m to A$8.8-9.0m (c19% upgrade to prospectus). Given XIP's exceptionally strong 1H16 result, FactSet consensus EBITDA had moved to A$8.6m for the full year with the upgrade implying a 2-5% improvement to consensus EBITDA. As anticipated the upgrade was driven by an 8% uplift in revenue, which reflects strong trading performance experienced across all areas of the business. We have made minor upgrades to our FY16 and FY17 forecasts, which see our EBITDA lift by 5% to A$9m (FY16) and 1% to A$9.7m. This has resulted in our EPS increasing by 7% in FY16 and 1% in FY17. We note that XIP's balance sheet remains well placed to fund acquisitions with the group sitting in a net cash position. We remain attracted to XIP's strong cash flow generation, high ROE and ability to consolidate the fragmented IP market. Read more for our recommendation: (VIEW LINK)


1 topic

1 stock mentioned

Morgans Financial Limited
Morgans Financial Limited
Stockbroker
Morgans Financial Limited

Morgans is Australia's largest national full-service retail stockbroking and wealth management network with over 240,000 client accounts, 500 authorised representatives and 950 employees operating from offices in all states and territories.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment